Zimmer Biomet beats quarterly estimates on strong hips, knees device demand

Chief Executive Ivan Tornos said in a statement the company expects a shift to a mostly direct and specialized U.S. sales model to weigh on 2026 sales growth, ‍but said it should support longer-term expansion.

Leave a Reply